< Back to previous page
Researcher
Els Dequeker
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Biomedical Quality Assurance Research Unit (Division)
Responsible
From1 Jan 2012 → Today - Biomedical Quality Assurance Research Unit (Division)
Member
From1 Jan 2012 → Today - Department of Human Genetics (Department)
Member
From1 Oct 1999 → 31 Dec 2011
Projects
1 - 10 of 12
- TBAFrom7 Oct 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Quality improvement in molecular pathology laboratories: providing the means of process management and standardization of pre-analytical handling of small biopsies.From15 Apr 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The changing HER2 biomarker testing policy: Impact and training for the Belgian pathology laboratoriesFrom12 Sep 2023 → 30 Aug 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Quality improvement of diagnostic processes in the oncology fieldFrom18 Oct 2021 → 15 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Evaluation of Scientific Publications to Predict the to be Expected Research Quality in Collaborations with External Service ProvidersFrom1 Oct 2021 → TodayFunding: Baekeland
- Quality improvement in molecular pathology laboratories: providing the means for process management and standardization of pre-analytical handling of small biopsies.From22 Apr 2021 → 8 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Organize distance laerning in the form of External Quality Assessment schemes.From1 Oct 2018 → 30 Sep 2019Funding: Private funding of national origin - undefined
- Early prediction/detection of clinical response in metastatic NSCLC by improving liquid biopsy analysisFrom4 Sep 2017 → 1 Jan 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Quality in Molecular Oncology Testing Laboratories in Europe: a View from Different AnglesFrom18 Jul 2016 → 22 Dec 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Quality improvement tools for predictive testing in pathologyFrom11 Sep 2015 → 28 Aug 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 92
- Defining, exploring the sources and expressing post-mortem diagnostic uncertainty(2025)Published in: Forensic Science, Medicine and PathologyISSN: 1547-769XIssue: 2Volume: 21
- Enhancing postmortem diagnostics: over a decade of ISO 17020 accreditation and guidelines implementation in forensic pathology(2025)Published in: Forensic Science, Medicine and PathologyISSN: 1547-769XIssue: 2Volume: 21
- Behind the scenes of EQA-characteristics, capabilities, benefits and assets of external quality assessment (EQA)(2025)Published in: Clinical Chemistry And Laboratory MedicineISSN: 1434-6621Issue: 5Volume: 63Pages: 879 - 897
- Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology(2024)Published in: VIRCHOWS ARCHIVISSN: 0945-6317Issue: 5Volume: 485Pages: 761 - 775
- Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research(2024)Published in: HistopathologyISSN: 0309-0167Issue: 6Volume: 84Pages: 915 - 923
- Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre(2024)Published in: Virology JournalISSN: 1743-422XIssue: 1Volume: 21
- The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study(2023)Published in: Clinical Breast CancerISSN: 1526-8209Issue: 4Volume: 23Pages: E273 - E280
- Quality in Molecular Oncology Testing Laboratories in Europe: a View from Different Angles(2022)
- Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment(2022)Published in: VIRCHOWS ARCHIVISSN: 0945-6317Issue: 3Volume: 481Pages: 351 - 366
- Recommendations for reporting results of diagnostic genomic testing(2022)Published in: EUROPEAN JOURNAL OF HUMAN GENETICSISSN: 1018-4813Issue: 9Volume: 30Pages: 1011 - 1016